Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Dec. 17, 2018. Philip Cuculich.

Executive Summary

Cardiologist Philip Cuculich, oncologist Clifford Robinson and other researchers at the University of Washington in St. Louis are working with US FDA to design a multicenter trial of their technique for noninvasive cardiac radioablation of ventricular tachycardia using stereotactic body radiation. See what Cuculich said about it here.

"The beauty of what we've invented here for patients is taking an eight-hour procedure and turning it into an 80-minute procedure as an outpatient. [This] is a major boon for patients and their safety and recovery from this type of procedure," –Philip Cuculich, cardiologist/electrophysiologist at Washington University in St. Louis

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT124380

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel